X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ADCOCK INGRAM
Jun-14
ORCHID PHARMA LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs194365-   
Low Rs35264-   
Sales per share (Unadj.) Rs276.5108.7-  
Earnings per share (Unadj.) Rs-79.2-27.4-  
Cash flow per share (Unadj.) Rs-43.5-22.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.985.3-  
Shares outstanding (eoy) m70.45168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.9 14.3%   
Avg P/E ratio x-1.4-11.5 12.6%  
P/CF ratio (eoy) x-2.6-13.9 19.0%  
Price / Book Value ratio x2.13.7 57.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,06753,081 15.2%   
No. of employees `0002.84.3 65.2%   
Total wages/salary Rs m2,5273,331 75.9%   
Avg. sales/employee Rs Th6,956.14,273.4 162.8%   
Avg. wages/employee Rs Th902.5776.0 116.3%   
Avg. net profit/employee Rs Th-1,993.0-1,076.8 185.1%   
INCOME DATA
Net Sales Rs m19,47718,346 106.2%  
Other income Rs m407128 317.0%   
Total revenues Rs m19,88418,474 107.6%   
Gross profit Rs m1,103-3,179 -34.7%  
Depreciation Rs m2,519792 318.2%   
Interest Rs m5,227497 1,051.8%   
Profit before tax Rs m-6,236-4,339 143.7%   
Minority Interest Rs m20-12 -162.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125271 -46.2%   
Profit after tax Rs m-5,580-4,623 120.7%  
Gross profit margin %5.7-17.3 -32.7%  
Effective tax rate %2.0-6.2 -32.1%   
Net profit margin %-28.7-25.2 113.7%  
BALANCE SHEET DATA
Current assets Rs m11,01413,437 82.0%   
Current liabilities Rs m32,0607,560 424.1%   
Net working cap to sales %-108.132.0 -337.3%  
Current ratio x0.31.8 19.3%  
Inventory Days Days95111 85.5%  
Debtors Days Days34124 27.1%  
Net fixed assets Rs m29,4407,832 375.9%   
Share capital Rs m70585 827.1%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,80014,399 26.4%   
Long term debt Rs m9,0185,060 178.2%   
Total assets Rs m46,51027,201 171.0%  
Interest coverage x-0.2-7.7 2.5%   
Debt to equity ratio x2.40.4 675.3%  
Sales to assets ratio x0.40.7 62.1%   
Return on assets %-0.8-15.2 5.0%  
Return on equity %-146.9-32.1 457.4%  
Return on capital %-3.7-19.8 18.9%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,6821,566 107.4%  
From Investments Rs m-9,860-481 2,050.8%  
From Financial Activity Rs m6,6444,592 144.7%  
Net Cashflow Rs m-1,5355,678 -27.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare ORCHID PHARMA LTD With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  CIPLA  SANOFI INDIA  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Nov 13, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS